𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients

✍ Scribed by R. L. Dobbins; R. O’Connor-Semmes; A. Kapur; C. Kapitza; G. Golor; I. Mikoshiba; W. Tao; E. K. Hussey

Book ID
109046198
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
612 KB
Volume
14
Category
Article
ISSN
1462-8902

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of a new specificα-amylase in
The effect of a new specificα-amylase inhibitor on post-prandial glucose and insulin excursions in normal subjects and Type 2 (non-insulin-dependent) diabetic patients
✍ H. G. Eichler; A. Korn; S. Gasic; W. Pirson; J. Businger 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 324 KB

Trestatin (Ro 9-0154), a new specific alpha-amylase inhibitor of microbial origin, was tested in six normal subjects and seven Type 2 (non-insulin-dependent) diabetic patients. In normal subjects the maximal increases in blood glucose following a 115-g starch meal were 2.19 +/- 0.57 mmol/l (mean +/-